The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Myopenia as a significant prognostic factor in BCLC-B intermediate-stage hepatocellular carcinoma treated with sorafenib.
 
Mao Okada
No Relationships to Disclose
 
Hiroyuki Nakanishi
No Relationships to Disclose
 
Masayuki Kurosaki
Consulting or Advisory Role - Abbvie; Bayer; Eisai; Gilead Sciences; Otsuka; Shionogi
Speakers' Bureau - Abbott; Abbvie; Bayer; Eisai; Gilead Sciences; Otsuka; Shionogi; Sysmex
 
Sakura Kirino
No Relationships to Disclose
 
Leona Osawa
No Relationships to Disclose
 
Keiya Watakabe
No Relationships to Disclose
 
Wan Wang
No Relationships to Disclose
 
Takao Shimizu
No Relationships to Disclose
 
Kenta Takaura
No Relationships to Disclose
 
Hitomi Takada
No Relationships to Disclose
 
Shun Kaneko
No Relationships to Disclose
 
Nobuharu Tamaki
No Relationships to Disclose
 
Yutaka Yasui
Speakers' Bureau - Bayer Yakuhin
 
Kaoru Tsuchiya
Consulting or Advisory Role - Bayer; Eisai
Speakers' Bureau - Bayer; Eisai
 
Jun Itakura
No Relationships to Disclose
 
Yuka Takahashi
No Relationships to Disclose
 
Namiki Izumi
Consulting or Advisory Role - Abbvie; Bayer; Eisai; Gilead Sciences; Otsuka; Shionogi
Speakers' Bureau - Abbott; Abbvie; Bayer; Eisai; Gilead Sciences; Otsuka; Shionogi; Sysmex